Holy Grail: Ilumina nabs cancer testing firm in $8B deal
September 21, 2020 -- Illumina has agreed to acquire cancer diagnostics startup Grail for $8 billion in cash and stock. Grail utilizes Illumina's next-generation sequencing (NGS) technology, data science, and machine learning to identify cancer signals in blood samples.
Genetic testing cut adverse events in heart patients
August 27, 2020 -- Personalized genetic testing led to a 34% decrease in the number of patients who had serious adverse events following balloon angioplasties, according to results published August 25 in the Journal of the American Medical Association.  Discuss
AI-based test diagnoses dental infection-related brain abscess
August 21, 2020 -- A pathogen detection test based on artificial intelligence (AI) was used to diagnose a patient's rare progressive brain abscess caused by a dental infection. Details were published on July 26 in a case report in the World Journal of Clinical Cases.  Discuss
Thermo Fisher debuts hematology/oncology assays
August 19, 2020 -- Thermo Fisher Scientific has debuted hematology/oncology assays that enable simultaneous analysis of DNA mutations and RNA fusion transcripts in myeloid samples in a day.
Sophia launches AI-powered SARS-CoV-2 analysis algorithm
August 11, 2020 -- Sophia Genetics has released a SARS-CoV-2 genome analysis algorithm that uses artificial intelligence (AI) to synthesize viral strain, genetic response, and clinical management data.
FDA approves Guardant's liquid biopsy NGS test
August 7, 2020 -- The U.S. Food and Drug Administration (FDA) has approved the first liquid biopsy companion diagnostic that also uses next-generation sequencing (NGS) to identify patients with specific types of EGFR mutations in a form of metastatic non-small cell lung cancer.
NanoString launches readout technology for NGS
August 4, 2020 -- NanoString Technologies has released Cancer Transcriptome Atlas, a new product based on the company's GeoMx digital spatial profiler platform that's optimized for readout on Illumina's next-generation sequencing (NGS) technology.
Top 10 LabPulse stories for 1st half of 2020
July 31, 2020 -- It comes as no surprise that COVID-19 dominated the news for the first half of 2020, as evidenced in a list we compiled of the articles most viewed by LabPulse.com members.  Discuss
NIH invests almost $249M in 7 COVID-19 test technologies
July 31, 2020 -- The U.S. National Institutes of Health (NIH) is touting the results of its "Shark Tank" approach to spurring development in COVID-19 testing technologies, with $248.7 million invested in a variety of different methods that promise rapid results.
PanCan, GeneCentric partner on precision medicine for pancreatic cancer
July 31, 2020 -- The Pancreatic Cancer Action Network (PanCan) and GeneCentric Therapeutics have partnered to conduct research on RNA-based molecular technologies to predict pancreatic cancer disease progression and drug response.